The Psychosomatic Pattern: Historical Parallels
ME/CFS is not the first disease to be dismissed as psychosomatic before its biological basis was established. A systematic review of the history of psychosomatic medicine reveals a recurring pattern across at least ten major diseases (ME/CFS Science 2021):
- Multiple sclerosis was considered psychosomatic for decades; patients were told their weakness was hysterical
- Asthma was attributed to the “asthma personality” and treated with psychotherapy
- Epilepsy was classified as a psychological condition and patients were institutionalized
- Diabetes was linked to emotional stress and treated with psychoanalysis
- Autism was blamed on “refrigerator mothers” who failed to bond with their children
- Schizophrenia was attributed to “schizophrenogenic mothers”
- Cancer was linked to suppressed emotions and the “cancer personality”
- Heart disease was attributed to the “Type A personality”
- Rheumatoid arthritis was considered a psychosomatic condition driven by emotional conflicts
- Peptic ulcer was treated with psychotherapy until Marshall and Warren discovered Helicobacter pylori in 1982—a condition assumed to be stress-related that turned out to have a specific biological cause
- Irritable bowel syndrome retains a functional diagnosis but now has validated pathophysiological subsets (bile acid malabsorption, post-infectious IBS with mast cell activation), illustrating that “functional” and “biological” are not mutually exclusive The peptic ulcer story is particularly instructive: despite clear evidence that H. pylori caused ulcers, the psychosomatic establishment resisted the biological explanation for years. Marshall famously infected himself to prove the point. The pattern—biological discovery → establishment resistance → eventual acceptance—has been repeated across several diseases on this list. Whether ME/CFS follows the same trajectory depends on the outcome of ongoing biological investigations, not on historical analogy alone. This historical context does not prove that ME/CFS has a specific biological cause, but it does demonstrate that medicine has a systematic tendency to classify poorly understood diseases as psychosomatic, and that this classification has consistently been wrong when biological investigation eventually catches up. The lesson is that absence of a known mechanism is not evidence for a psychological cause. The question then becomes: what would the equivalent of Marshall’s H. pylori discovery look like for ME/CFS? The Peptic Ulcer Parallel speculation (Chapter Integrative Models and Multi-System Pathophysiology, Speculation Integrative Speculations) identifies three candidates for the “molecular switch” that maintains ME/CFS independently of the original trigger: (1) TRPM3 ion channel dysfunction affecting calcium signalling across immune, neuronal, and metabolic cells (Chapter Immune System Dysfunction); (2) epigenetic methylation locks at autonomic regulatory genes that persist after the triggering infection resolves; (3) a genetic bottleneck in mitophagy capacity revealed by the DecodeME autophagy genes FBXL4 and CCPG1 (Chapter Genetic and Epigenetic Factors, Hypothesis Genetic Mitophagy Vulnerability: The Accumulation Threshold Model). Each candidate predicts a different “eradication therapy”—TRPM3-restoring drugs, targeted demethylation agents, or mitophagy enhancers—but all share the peptic ulcer pattern: a simple persistent factor maintaining a complex disease that was assumed to be psychosomatic.
Historical patterns suggest that the decline in psychologization after biomarker discovery is real but slow: peptic ulcer (Marshall 1984), SLE (LE cell 1948 → ANA standard), and multiple sclerosis (MRI introduction 1980s) each show a multi-decade lag between first compelling biological evidence and widespread clinical acceptance. A sufficiently specific biomarker (ANA for SLE, H. pylori for ulcer, MRI for MS) appears capable of reducing psychologization, but not instantaneously and not completely — some residual tendency to attribute symptoms to psychology persists even after a biomarker is available, particularly for female patients, atypical presentations, and patients who test negative for standard markers despite having the disease. The precise duration of the lag and how well it generalises across different diseases are unknown; the three cases are illustrative, not a formal statistical sample.
This pattern has implications for ME/CFS. Any validated biomarker would likely reduce but not eliminate psychologization, following a lag whose duration cannot be predicted from three historical cases. Psychologization may also decline without a single definitive biomarker if a convergent body of objective physiological abnormalities reaches clinical consensus — a trajectory ME/CFS may already be on, given the accumulation of immunological, metabolic, and autonomic findings documented in the pathophysiology chapters. The post-COVID Long COVID connection may accelerate this trajectory through a “legitimacy spillover”: clinicians and researchers who develop LC and experience PEM firsthand are less likely to attribute it to psychological causes.
Fibromyalgia provides a counter-example: despite accumulating biomarker evidence (small fiber neuropathy, neuroinflammation by PET, central sensitization by fMRI), the condition remains heavily psychologized. Observational differences that may contribute include the absence of a clear post-infectious trigger cohort analogous to LC, the 80% female patient skew, and the lack of a single decisive biomarker. This is a comparison drawn after the fact, not a prediction — whether ME/CFS follows the trajectory of MS/SLE (partial decline in psychologization) or fibromyalgia (persistent psychologization) is unknown and depends on factors beyond biomarker discovery alone, including institutional, political, and cultural dynamics.
(Certainty: 0.40. The core observation (biomarker discovery tends to reduce psychologization) is grounded in historical cases but the quantitative features (lag duration, residue rate, fibromyalgia comparison) are extrapolated from a small, non-systematic set of examples and should be treated as qualitative pattern recognition, not quantitative prediction. Origin: brainstorm.)